Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Quest Diagnostics (NYSE: DGX) will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026 at 4:30 p.m. PT. Jim Davis, Chairman, CEO and President, and Sam Samad, EVP and CFO, will discuss the company’s strategy, performance, and market trends during a presentation and Q&A.

The session will be webcast live and available at ir.QuestDiagnostics.com; an archived webcast will be posted within 24 hours and will remain available through February 11, 2026.

News Market Reaction – DGX

-0.05%

-0.05% Session close to close

In the Dec 19 session, DGX declined 0.05%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement focused on Quest Diagnostics’ participation in the 44th J.P. Morgan Healthcare Con...

Analysis

This announcement focused on Quest Diagnostics’ participation in the 44th J.P. Morgan Healthcare Conference, where senior leadership planned to discuss strategy and market trends on January 12, 2026. A live and archived webcast, available through February 11, 2026, offered investors additional insight beyond standard filings. Observers would typically track any new strategic details or long-term priorities discussed during the presentation.

Key Figures

Conference edition: 44th Annual Presentation date: January 12, 2026 Webcast availability: Until February 11, 2026

3 metrics

Conference edition 44th Annual J.P. Morgan Healthcare Conference

Presentation date January 12, 2026 Company presentation at 4:30 p.m. Pacific Time

Webcast availability Until February 11, 2026 Archived conference webcast access window

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECAUCUS, N.J., Dec. 19, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading national provider of diagnostic information services, announced that Jim Davis, Chairman, CEO and President, and Sam Samad, Executive Vice President and Chief Financial Officer, will speak on the company's strategy, performance, and the latest market developments and trends during a presentation and Q&A session at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026, at 4:30 p.m. Pacific Time.

The presentation and Q&A session will be webcast live during the conference and will be available at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until February 11, 2026.

About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our more than 55,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. www.QuestDiagnostics.com. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-44th-annual-jp-morgan-healthcare-conference-302647252.html

SOURCE Quest Diagnostics

FAQ

When will Quest Diagnostics (DGX) present at the J.P. Morgan Healthcare Conference?

Quest Diagnostics will present on January 12, 2026 at 4:30 p.m. Pacific Time.

Who from Quest Diagnostics (DGX) will speak at the January 12, 2026 presentation?

Jim Davis (Chairman, CEO and President) and Sam Samad (EVP and CFO) will speak and take questions.

How can investors watch the Quest Diagnostics (DGX) presentation at J.P. Morgan?

The presentation and Q&A will be webcast live and accessible at ir.QuestDiagnostics.com.

When will the archived webcast of Quest Diagnostics (DGX) be available after the live event?

The archived webcast will be posted within 24 hours after the live event.

How long will the Quest Diagnostics (DGX) archived webcast remain available?

The archived webcast will remain available through February 11, 2026.